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Abstract: p21WAF1/Cip1 belongs to the Cip/Kip family of cyclin kinase inhibitors (CKI) (p21Waf1/Cip1, 
p27Kip1, p57Kip1). p21Waf1/Cip1 was first described as a potent and universal inhibitor of cyclin-dependent 
kinases (Cdks). Two forms of functionally active p21 has been localized and described: a nuclear and a 
cytoplasmic forms. In this paper the structures of p21 has been described and as well as it functional 
biology in terms of differentiation, proliferation and apoptotic activities. The upregulation of p21 by 
p53-dependent and p53-independent mechanisms is also described. 
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INTRODUCTION 
 
 p21WAF1/Cip1 belongs to the Cip/Kip family of cyclin 
kinase inhibitors (CKI) (p21Waf1/Cip1, p27Kip1, p57Kip1). 
p21Waf1/Cip1 was first described as a potent and universal 
inhibitor of cyclin-dependent kinases (Cdks)[1]. p21 
functions as a checkpoint in the cell cycle by inhibiting 
cdks at the G1/S and G2/M interfaces[2]. p21 has been 
shown to bind to cyclin-cdk complexes, preventing 
phosphorylation of the retinoblastoma protein[3]. When 
this happens the E2F pathway is blocked and the cell 
cycle is arrested at the G1/S interface[4].  
 Variation in the p21 levels has been shown in 
epithelial cells in several lung diseases[5], upon cell-
matrix disruption[6] and to be influenced by several 
integrins[7].  
 p21 expression is usually controlled at the 
transcriptional level by either the p53-dependent or -
independent pathway[8], but p21 expression can also be 
regulated at the post-transcriptional level. Short 
wavelength UVC was found to induce p21 in a p53-
dependent fashion by post-transcriptional modifications 
that led to enhanced stability of p21 mRNA[9]. The 
transcription factors C/EBPα and C/EBPβ were found 
to interact with p21 protein and protect it from 
proteolytic degradation[10]. In a number of other cell 
lines, post-transcriptional events strongly influence p21 
expression following genotoxic stress[11]. Stress-
activated kinases p38α and JNK 1 were shown to 
stabilise p21 by phosphorylation at serine 130[12].  
 p21 was shown to promote apoptosis[13], protect 
cells from undergoing apoptosis[14, inhibit 
differentiation[15] and promote differentiation.  
 
Structure and protein interactions of p21Waf1/Cip1: 
Cip/Kip family (p21Waf1/Cip1, p27Kip1, p57Kip2 share 
significant sequence homology in their amino-terminal. 
The amino-terminal domain of p21, like the 
corresponding domains of p27 or p57, is both necessary 
and sufficient to inhibit cyclin/CDK activity. The 
unique carboxy-terminal domain of p21Waf1/Cip1 
associated with the proliferating nuclear antigen 
(PCNA), a subunit of DNA polymerase δ and can 
inhibit DNA replication directly, without affecting 
DNA repair[16].  
 p21Waf1/Cip1 was identified as a mediator of p53-
induced growth arrest[17] and a direct regulator of CDK 
activity[18]. p21Waf1/Cip1 plays a critical role in the 
negative control of cell growth and is generally up-
regulated in cell arrest either by cell contact, serum 
deprivation, differentiation or senescence[4]. 
 The human p21 gene consists of 3 exons (68, 450 
and 1600 bp) but the first exon is not translated. The 
human p21 protein is 164 amino acids with a molecular 
mass of 21 kDa and has been conserved during 
evolution[19]. p21Waf1/Cip1 interacts directly with cyclins 
through a conserved region close to the N-terminus 
(Cyc 1), however it has a second weak cyclin binding 
near its C-terminus region (Cyc 2), which overlaps with 
its PCNA binding region domain. Moreover, p21 has a 
separate cyclin-dependant kinase domain (Cdk) binding 
site in its N-terminus region[20]. For optimal cyclin-Cdk 
inhibition, the binding to this site as well as one of the 
cyclins is required. p21 was shown to compete with 
p107 and p130 for binding to cyclin/Cdks and to disrupt 
already formed complexes among these molecules[21]. 
 p21 was found to cause repression of the E2F-
dependent transcription possibly by direct association 
with E2F factor[22]. This means that E2F could function 
as an anchor of p21, bringing it in juxtaposition with an 
E2F-dependent transcription initiation complex, thereby 
inhibiting its function[4]. 
 p21 can bind to the N-terminus of c-Myc, to 
interfere with the c-Myc-Max association, but at the 
same time, the interaction between c-Myc and p21 can 
directly counteract p21-dependent inhibition of DNA 
synthesis, as c-Myc binds to the C-terminus of p21 in 
competition with PCNA[23] 
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 p21 can enhance the function of transcription co-
activators such as p300[24]. The ability of p300 to 
interact with NFB-dependent transcription is 
negatively controlled by association of p300 with active 
cyclin/CDK complexes. Thus the inhibition of 
cyclin/CDK activity could be a way of explaining the 
capability of p21 to activate p300-dependent 
transcription. It was shown that stimulation of p300 
activity could occur by p21 independently of the 
intrinsic histone acetyltransferase activity of this co-
activator and its cyclin/CDK binding region. This 
occurs because p21 can relieve the effects of a 
previously uncharacterised transcription repression 
domain present in p300[24].  
 The E7 protein of human papilloma virus 16 
(HPV-16) binds to p21 and competes with PCNA for 
binding to the carboxy-terminus domain of p21[25,26]. 
The association of E7 to p21, blocks the ability of p21 
to inhibit cyclin/CDK activity as well as PCNA-
dependent DNA synthesis. E7 does not disrupt the 
association of p21 with cyclin/CDK complexes, but it is 
thought to relieve p21-dependent suppression of CDK 
activity[27]. 
 Two DNA metabolising enzymes Fen 1 (Fap 
endonuclease I) and DNA-(cytosine-5) 
methytransferase (DNA MTase) bind to p21 in 
competition with PCNA. PCNA interacts physically 
with Fen I and stimulates its enzymatic activity. The 
central residues of the PCNA binding domain of p21 
are the most highly conserved with Fen 1 and likely to 
mediate their mutually exclusive binding to PCNA[28]. 
DNA MTase was shown to bind directly to PCNA and 
the PCNA-DNA MTase association was disrupted by 
p21. Newly replicated DNA must be methylated before 
histone H1 is incorporated into the nucleosome. This 
suggests that p21 can control DNA methylation levels 
during replication and possibly during DNA repair[29]. 
 In addition to DNA metabolising enzymes, 
GADD45 is also involved in p21-PCNA interactions. 
GADD45, like p21 is a nuclear protein and has been 
implicated in induction of growth arrest, apoptosis, 
excision repair and DNA stability[30]. Although 
GADD45 interacts with PCNA through a region 
distinct from that recognised by p21, both p21 and 
GADD45 compete with each other to bind PCNA[31]. 
GADD45 and its related homologue MyD118, can 
directly associate with p21[32]. GADD45 does not 
appear to inhibit cyclin-Cdk complexes either by itself 
or in combination of p21[33]. 
 p21 binds directly to procaspase 3 at its N-terminus 
and is involved in death induction and suppression. p21 
also bind to SAPK at its N-terminus and was found to 
block its phosphorylation and also the activation by the 
upstream MKK4 kinase[34]. 
 p21 was shown to interact with other regulatory 
proteins, such as protein kinase, CK2[35], calmodulin 
(CaM)[36],   a    novel    cell    regulatory     protein with  
 
 
 
Fig. 1: p21 regulation via the p53 dependent pathway. p53 induction 
may lead cells down the apoptotic pathway, by upregulating 
Bax and downregulating a survival factor, Bcl-2. 
Transcriptionally induced p21 by p53 may prevent this and 
instead lead to cell cycle arrest. Adapted from[50] 
 
oncogenic potential, SET[37] and the transcription factor 
C/EBP-α[38].  
 The cell-cycle inhibitory activity of p21Cip1/Waf1 is 
associated with its nuclear localisation. However a 10-
amino acid truncation from the C-terminal form of p21 
was reported in UV-irradiated normal diploid 
fibroblasts and many tumour cells mainly localised in 
the cytoplasm[39]. 
 A physical association between cytoplasmic p21 
and ASK1 has been described and was found to 
suppress the activity of ASK 1 and MAPK 
(SAPK/JNK) cascade activation thus preventing the cell 
from undergoing apoptosis[40]. It has been suggested 
that cytoplasmic p21 is formed by cleavage or 
truncation during apoptosis[41]. Other forms of 
cytoplasmic p21 have been described but their roles are 
still unclear[42]. 
  
p53-dependent induction of p21 transcription: The 
p53 tumour suppressor protein is an inducible 
transcription factor required for the transactivation of a 
number of genes involved in cell cycle control[43]. p21 
expression is normal in embryos and most tissues from 
p53 knockout (p53 -/-) mice[44].  
 Although p53 is not required for p21 transcription, 
the regulation of p21 is p53-dependent following DNA 
damage by γ-radiation[44]. Cultured p21-deficient mouse 
embryonic fibroblasts still had the ability to undergo G1 
arrest in response to DNA damage, thus p53 may 
induce an additional gene that participates in cell 
arrest[45]. p21 transcription and cell cycle arrest was 
observed in irradiated human cell lines[46].  
 The expression of p21 was found to increase via 
the p53-dependent pathway in murine embryonic 
fibroblasts following treatment with the spindle 
disrupter nocodazole[47]. Ribonucleotide biosynthesis 
inhibitors such as pyrazofurin and 
cyclopentenylcytosine were shown to induce p53-
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dependent p21 expression in the absence of DNA 
damage and resulted in hypophosphorylation of 
retinoblastoma in normal human fibroblasts and cell 
growth arrest[48]. 
 Transcriptional induction of p21 by p53 may 
prevent cells undergoing apoptosis and instead lead to 
cell-cycle arrest[49]. A summary of the induction of p21 
via the p53-dependent pathway and control of apoptosis 
via p21 is shown in Fig. 1. 
 
p53-independent regulation of p21 expression: A 
number of agents activate p21 transcription independent 
of the p53 pathway. These agents induce binding of 
different transcription factors to specific cis-acting 
elements located within the p21 promoter . The region 
between -119 bp and start of transcription of the human 
p21 gene contains six Sp1 binding sites (Sp1-1 to Sp1-
6). Sp1 is a member of a multigene family that binds to 
DNA through C-terminal zinc-finger motifs. Sp2, Sp3 
and Sp4 share extensive structural and sequence 
homology with Sp1[51].  
 Phorbol ester (PMA) and okadaic acid induce p21 
through Sp1[51]. The tumour suppressor protein BRCA1 
activates p21 via the region from -143 to -93 bp which 
contains the Sp1-1 and Sp1-2 sites and inhibits DNA 
synthesis[52]. Transforming growth factor-β (TGF-β)[53], 
calcium[54], butyrate[55], lovastatin[56], histone 
deacetylase inhibitor Trichostatin A (TSA)[55] and nerve 
growth factor (NGF)[57] has been shown to induce p21 
via the Sp1-3 site in the p21 promoter. TGF-β and 
butyrate inhibited proliferation and induced G1 cell 
cycle arrest in various cells[53], calcium induced 
differentiation of cultured mouse keratinocytes[54] 
whereas lovastatin induced cell cycle arrest in p53-null 
human prostate carcinoma cells[56]. 
 The addition of nerve growth factor (NGF) to 
PC12 cells induced p21 expression and differentiation 
through Sp1, Sp3 sites and p300 transcriptional co-
activator[58]. Progesterone was found to increase the 
level of p21 and promote growth arrest. The 
progesterone receptor (PR) was found complexed with 
p300 and Sp1[59]. A variety of other transcription factors 
such as AP2[60], E2F[61], STATs[62] and C/EBPα[38] can 
induce p21 transcription in response to different signals.  
 
p21 and differentiation: Exit from the cell cycle is a 
prerequisite for terminal differentiation and p21 
expression is induced during terminal differentiation 
both in vitro and in vivo[63,64]. p21 expression promotes 
differentiation in megakaryoblast leukemia cell line 
(CMK)[65], in megakaryocytes cells (CD34+)[66], in 
myelomonocytic cell line (U937)[67], in 
chondrosarcoma cells (SW1353)[68], in dendritic cells 
and macrophages from human peripheral blood 
monocytes[69], in skeletal muscles[70], in mice lungs[70], 
in peripheral nervous system neurons in response to 
nerve growth factor mediated by p300 protein[57], in 
myotube differentiation from myoblasts under the 
influence of the transcription factor MyoD[63] and in 
laryngeal tumours[71]. Interestingly, p21 was also shown 
to inhibit differentiation in terminally differentiated of 
mouse keratinocytes[72] but not those of humans[15] and 
decrease differentiation in human colon cancer cell line 
HT29[73]. The p21 was found not to be involved in the 
regulation of differentiation of the mouse skin 
tumours[74] and in mouse keratinocytes[75]. 
 In the p21 null mice, normal differentiation has 
been observed thus implying that p21 is not a mutually 
exclusive agent that promotes differentiation[76]. 
Various other genes are thought to be involved and 
maybe cooperate with p21 to regulate differentiation 
including p15[76], p16[77], p18[76], p19[76], p27[77], p53[78], 
p57[79] and Rb[78]. 
 
p21 and proliferation: p21 is usually assumed to 
inhibit proliferation both in vitro and in vivo[80] and by 
the introduction of p21 expression constructs into 
normal[11] and tumour cell lines[19] resulted in cell cycle 
arrest at the G1 phase of the cell cycle[81]. 
Paradoxically, p21 has been shown to promote 
proliferation under certain circumstances[82]. 
 Various mechanisms have been described by which 
p21 can regulate proliferation[83]. p21 may induce 
growth arrest by inhibiting the activity of cyclin-
dependent kinases (Cdks) or of proliferating cell 
nuclear antigen (PCNA)[84]. The unique carboxy-
terminal domain of p21 can associate with PCNA and 
DNA polymerase δ and ε and can inhibit DNA 
replication directly, without affecting DNA repair[20]. 
p21 may act as an assembly factor for Cdk/cyclin 
complexes. p21 was found to promotes the assembly of 
Cdk4/6 and cyclin D in vitro and was found associated 
with cyclinD/Cdk4 complexes during cell-cycle 
progression[85]. p21 was also shown to complex with 
cdk2 and thus lead to growth arrest[86]. The role of p21 
as an assembly activator or inhibitor depends on its 
expression level. At low and intermediate 
concentrations it is an assembly factor, while at high 
concentrations it is an inhibitor[87]. 
 p21 has been shown to be part of a quaternary 
complex that contains cyclin, Cdk and PCNA[88]. The 
transition between active and inactive states occurs 
through changes in p21 stoichiometry, particularly 
when multiple p21 molecules versus a single p21 
molecule bind to these complexes[81]. 
 The role of p21 to either promote or inhibit 
proliferation could depend on the specific cellular 
context[89]. Mammary tumour-susceptible MMTV-ras 
mice displayed higher S-phase fractions and an increase 
in tumours in p21 knockout mice, whereas MMTV-c-
Myc exhibited lower S-phase and a decrease in 
tumours[89]. Summary of the regulation of proliferation 
by p21 is shown in Fig. 2. 
 
p21 and apoptosis: p21 can both promote and inhibit 
apoptosis    although     it     generally    counteracts  the  
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Fig. 2: Regulation of proliferation by p21. (A) p21 can form a 
complex with Cdk, Cyclin and PCNA. (B) At low or 
intermediate conc. of p21 it promotes proliferation while at 
high p21 conc. the complex is inactive thus inhibiting 
proliferation. (C) p21 can inhibit the activity of PCNA 
complex with DNA polymerase  and  and (D) Cdk/Cyclin 
complex or act as an assembly factor for Cdk/Cyclin 
complexes. (E) p21 can also associate with the Cdk/Cyclin 
complexes and can inhibit or promote proliferation 
 
apoptotic process[4]. p53-dependent apoptosis occurs 
normally in cells from p21 knockout mice[90]. 
Expression of p21 appears to protect colorectal 
carcinoma and melanoma cells from p53-induced 
apoptosis[91], while suppression of p21 expression by 
anti-sense technology and homologous recombinations 
was shown to shift cells from the cell-cycle arrest 
pathway to apoptosis[49]. While the majority of evidence 
supports a role of p21 in protection against apoptosis, 
over-expression of p21 has been associated with the 
induction of apoptosis in human retinoblastoma cells 
lines[92] and T-cells[93].  
 Cells from p21 knockout mice were shown to 
contain very high levels of apoptosis after γ-
irradiation[94]. These findings might suggest that p21 
protein normally protects cells from undergoing p53-
mediated apoptosis by holding them in cell-cycle 
arrest[95] (Fig. 2). 
 Activation of the MAPKs of the SAPK (JNK) and 
p38 kinase families are also key events in the apoptotic 
response of many cells and p21 has been found to 
associate and control both types of molecules[12]. p21 
was also found to form complexes with caspase 3[41] 
and MEKKs (ASK1)[40]. The association with these 
molecules could be favoured by the fact that p21 itself 
is a caspase substrate and becomes localised to the 
cytoplasm as a consequence of caspase-dependent 
cleavage of its nuclear localisation C-terminus domain 
and is unable to suppress growth as well as 
apoptosis[13]. This truncation would also compromise 
the ability of p21 to promote cyclin/CDK nuclear 
localisation, with the same biological end point 
effect[14]. 
 p21 can also protect cells from undergoing 
apoptosis due to the cyclin/CDK inhibition[16]. Direct 
interaction between p21 and GADD45 is thought to 
promote apoptosis rather than cell cycle arrest[30]. 
 Two novel proteins, p21B and p21C, which are 
variants of p21 were found to be induced by DNA 
damage, p53 and p73. p21B have two unique exons and 
encodes a protein that is not homologous to p21 or any  
 
 
Fig. 3: Regulation of apoptosis by p21. p21 can inhibit apoptosis by 
complexing with cyclin/CDK, Gadd45, p38 kinase, SAPK 
and can inhibit the p53-dependent apoptosis pathway. p21 
can also regulate Gadd45 and procaspase 3 leading to 
apoptosis. Caspase 3 can truncate nuclear p21 at the C-
terminal thus losing the nuclear localisation signal and is 
located in the cytoplasm, whereby it cannot suppress growth 
arrest as well as apoptosis 
 
other known protein. p21B was found to induce cell 
cycle arrest and apoptosis. p21C uses an extended 
version of the p21B exon I, but is spliced to the second 
and third exons of p21 and encodes the p21 protein[96]. 
Summary of the regulation of apoptosis by p21 is 
shown in Fig. 3. 
 
CONCLUSION 
 
 p21 can be localised in both nuclear and cytoplasic 
regions and yet have different functional roles. It is not 
easy to describe the exact function of p21 since of its 
vast array of regulatory pathways and interactions. 
Although traditionally p21 was believe to be localised 
only in the nucleus, cytoplasmic p21 seems to be an 
interesting missing link and need to be studied further 
in order to fully understand the full biological 
significance of p21. 
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